Bath & Body Works (NYSE:BBWI) PT decreased to $38.00

Bath & Body Works (NYSE:BBWI – Get Free Report) had its price objective lowered by equities researchers at UBS Group from $52.00 to $38.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. UBS Group’s price target indicates a potential upside of 17.72% from the stock’s previous close.

Other equities analysts have recently issued research reports on the company. Piper Sandler decreased their price objective on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, July 11th. JPMorgan Chase & Co. raised Bath & Body Works from an “underweight” rating to a “neutral” rating and boosted their price target for the company from $40.00 to $53.00 in a research report on Friday, May 17th . Citigroup cut their price target on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 20th. Barclays decreased their price objective on Bath & Body Works from $45.00 to $32.00 and set an “equal weight” rating for the company in a report on Wednesday, August 7th. Finally, Telsey Advisory Group restated an “outperform” rating and set a $53.00 target price on shares of Bath & Body Works in a report on Wednesday. Eight research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company currently has an average rating of “Moderate Buy” and a consensus price target of $44.06, according to MarketBeat.com.

Check out our latest analysis of BBWI

Bath & Body Works stocks down 7.0%

NYSE:BBWI opened at $32.28 on Thursday. The company has a market cap of $7.21 billion, a P/E ratio of 8.32, a price-to-earnings-growth ratio of 1.16 and a beta of 1.85. Bath & Body Works has a twelve month low of $27.30 and a twelve month high of $52.99. The company has a 50 day moving average price of $35.91 and a two hundred day moving average price of $42.77.

Bath & Body Works (NYSE:BBWI – Get Your Free Report ) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.54 billion. Bath & Body Works had a net margin of 11.92% and a negative return on equity of 40.00%. As a group, analysts anticipate that Bath & Body Works will post 3.29 earnings per share for the current fiscal year.

Institutional inputs and outputs

Large investors have recently bought and sold shares of the stock. GAMMA Investing LLC bought a new stake in shares of Bath & Body Works in the fourth quarter valued at approximately $27,000. First Community Trust NA bought a new stake in Bath & Body Works in the second quarter valued at $30,000. EverSource Wealth Advisors LLC grew its position in Bath & Body Works by 72.0% during the 4th quarter. EverSource Wealth Advisors LLC now owns 805 shares of the company’s stock worth $35,000 after buying an additional 337 shares in the period time. Federated Hermes Inc. increased its position in Bath & Body Works by 17.1% during the fourth quarter. Federated Hermes Inc. now owns 1,612 shares of the company’s stock worth $70,000 after acquiring an additional 235 shares during the period. Finally, TFO Wealth Partners LLC boosted its stake in Bath & Body Works by 9,664.7% in the 4th quarter. TFO Wealth Partners LLC now owns 1,660 shares of the company’s stock worth $72,000 after acquired an additional 1,643 shares in the last quarter. 95.14% of shares are held by institutional investors.

Bath & Body Works Company Profile

(Get a free report)

Bath & Body Works, Inc operates a specialty retailer of home fragrances, body care and soaps and disinfectant products. It sells its products under the Bath & Body Works, White Barn and other brands through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by franchise, license and wholesale partners . arrangements.

Featured stories

Get daily Bath & Body Works news and reviews – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Bath & Body Works and related companies with MarketBeat.com’s FREE daily email newsletter.